$ELDN Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Eledon Pharmaceuticals, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Eledon Pharmaceuticals, Inc.. Get notifications about new insider transactions in Eledon Pharmaceuticals, Inc. for free.

Page: 1 2 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 10 2021	ELDN	Eledon Pharmaceuti ...	Gros David-Alexandre C	Chief Executive Off ...	Buy	P	8.01	3,000	24,030	3,000	0 to 3 K
May 04 2021	ELDN	Eledon Pharmaceuti ...	Smith Bryan E.	See Remarks	Option Exercise	A	9.91	158,500	1,570,735	158,500
Dec 28 2020	NVUS	Eledon Pharmaceuti ...	BVF PARTNERS L P/IL		Option Exercise	C	0.00	1,757	0	6,758
Dec 28 2020	NVUS	Eledon Pharmaceuti ...	BVF PARTNERS L P/IL		Option Exercise	C	0.00	9,169	0	39,693
Dec 28 2020	NVUS	Eledon Pharmaceuti ...	BVF PARTNERS L P/IL		Option Exercise	C	0.00	11,776	0	52,145
Dec 28 2020	NVUS	Eledon Pharmaceuti ...	BVF PARTNERS L P/IL		Option Exercise	C	0.00	35	0	0
Dec 28 2020	NVUS	Eledon Pharmaceuti ...	BVF PARTNERS L P/IL		Option Exercise	C	0.00	203	0	0
Dec 28 2020	NVUS	Eledon Pharmaceuti ...	BVF PARTNERS L P/IL		Option Exercise	C	0.00	273	0	0
Dec 28 2020	NVUS	Eledon Pharmaceuti ...	BVF PARTNERS L P/IL		Buy	C	0.00	97,615	0	113,152	15.5 K to 113.2 K (+628.27 %)
Dec 28 2020	NVUS	Eledon Pharmaceuti ...	BVF PARTNERS L P/IL		Buy	C	0.00	1,944	0	15,537	13.6 K to 15.5 K (+14.30 %)
Dec 28 2020	NVUS	Eledon Pharmaceuti ...	BVF PARTNERS L P/IL		Buy	C	0.00	509,410	0	598,624	89.2 K to 598.6 K (+571.00 %)
Dec 28 2020	NVUS	Eledon Pharmaceuti ...	BVF PARTNERS L P/IL		Buy	C	0.00	11,278	0	89,214	77.9 K to 89.2 K (+14.47 %)
Dec 28 2020	NVUS	Eledon Pharmaceuti ...	BVF PARTNERS L P/IL		Buy	C	0.00	654,215	0	771,780	117.6 K to 771.8 K (+556.47 %)
Dec 28 2020	NVUS	Eledon Pharmaceuti ...	BVF PARTNERS L P/IL		Buy	C	0.00	15,166	0	117,565	102.4 K to 117.6 K (+14.81 %)
Dec 04 2020	NVUS	Novus Therapeutics ...	OrbiMed Israel GP Ltd.	10% Owner	Sell	S	21.60	103,200	2,229,120	73,650	176.9 K to 73.7 K (-58.35 %)
Nov 06 2020	NVUS	Novus Therapeutics ...	Logos Global Management LP	10% Owner	Buy	P	25.55	9,098	232,460	224,071	215 K to 224.1 K (+4.23 %)
Nov 06 2020	NVUS	Novus Therapeutics ...	Logos Global Management LP	10% Owner	Buy	P	26.17	15,000	392,610	214,973	200 K to 215 K (+7.50 %)
Nov 06 2020	NVUS	Novus Therapeutics ...	Logos Global Management LP	10% Owner	Sell	S	27.02	27	730	199,973	200 K to 200 K (-0.01 %)
Nov 06 2020	NVUS	Novus Therapeutics ...	Logos Global Management LP	10% Owner	Buy	P	25.88	12,942	334,926	200,000	187.1 K to 200 K (+6.92 %)
Nov 06 2020	NVUS	Novus Therapeutics ...	Logos Global Management LP	10% Owner	Sell	S	26.64	12,942	344,829	187,058	200 K to 187.1 K (-6.47 %)
Nov 06 2020	NVUS	Novus Therapeutics ...	Logos Global Management LP	10% Owner	Buy	P	26.48	15,000	397,236	200,000	185 K to 200 K (+8.11 %)
Nov 06 2020	NVUS	Novus Therapeutics ...	Logos Global Management LP	10% Owner	Buy	P	25.97	4,000	103,892	185,000	181 K to 185 K (+2.21 %)
Nov 06 2020	NVUS	Novus Therapeutics ...	Logos Global Management LP	10% Owner	Buy	P	24.53	31,000	760,427	181,000	150 K to 181 K (+20.67 %)
Nov 06 2020	NVUS	Novus Therapeutics ...	Logos Global Management LP	10% Owner	Buy	P	24.03	5,000	120,163	150,000	145 K to 150 K (+3.45 %)
Sep 15 2020	NVUS	Novus Therapeutics ...	LYONS GARY A	Director	Option Exercise	A	500.00	1,167	583,500	1,167
Sep 15 2020	NVUS	Novus Therapeutics ...	Kuwahara Jon	See Remarks	Option Exercise	A	500.00	2,145	1,072,500	2,145
Sep 15 2020	NVUS	Novus Therapeutics ...	Gros David-Alexandre C	Chief Executive Off ...	Option Exercise	A	500.00	18,278	9,139,000	18,278
Sep 15 2020	NVUS	Novus Therapeutics ...	Katkin Keith	Director	Option Exercise	A	500.00	5,907	2,953,500	5,907
Sep 15 2020	NVUS	Novus Therapeutics ...	McBride John S.	Director	Option Exercise	A	500.00	1,167	583,500	1,167
Mar 20 2020	NVUS	Novus Therapeutics ...	FLESHER GREGORY J.	Chief Executive Off ...	Option Exercise	A	0.26	200,000	52,000	200,000
Mar 20 2020	NVUS	Novus Therapeutics ...	TURKEL CATHERINE C.	President	Option Exercise	A	0.26	100,000	26,000	100,000
Mar 20 2020	NVUS	Novus Therapeutics ...	Kuwahara Jon	See Remarks	Option Exercise	A	0.26	50,000	13,000	50,000
Feb 25 2020	NVUS	Novus Therapeutics ...	OrbiMed Israel GP Ltd.	Director	Option Exercise	S	0.00	646,204	0	0
Feb 25 2020	NVUS	Novus Therapeutics ...	OrbiMed Israel GP Ltd.	Director	Option Exercise	S	0.00	646,204	0	0
Feb 25 2020	NVUS	Novus Therapeutics ...	Chimovits Erez	Director	Option Exercise	S	0.00	646,204	0	0
Feb 25 2020	NVUS	Novus Therapeutics ...	Chimovits Erez	Director	Option Exercise	S	0.00	646,204	0	0
Sep 30 2019	NVUS	Novus Therapeutics ...	Kuwahara Jon	See Remarks	Option Exercise	A	0.67	60,000	40,200	60,000
Sep 30 2019	NVUS	Novus Therapeutics ...	Kuwahara Jon	See Remarks	Option Exercise	A	0.67	60,000	40,200	60,000
Sep 30 2019	NVUS	Novus Therapeutics ...	TURKEL CATHERINE C.	President	Option Exercise	A	0.67	75,000	50,250	75,000
Sep 30 2019	NVUS	Novus Therapeutics ...	TURKEL CATHERINE C.	President	Option Exercise	A	0.67	75,000	50,250	75,000
Sep 30 2019	NVUS	Novus Therapeutics ...	FLESHER GREGORY J.	Chief Executive Off ...	Option Exercise	A	0.67	100,000	67,000	100,000
Sep 30 2019	NVUS	Novus Therapeutics ...	FLESHER GREGORY J.	Chief Executive Off ...	Option Exercise	A	0.67	100,000	67,000	100,000
Jul 15 2019	NVUS	Novus Therapeutics ...	McBride John S.	Director	Option Exercise	A	0.88	20,000	17,600	20,000
Jul 15 2019	NVUS	Novus Therapeutics ...	Katkin Keith	Director	Option Exercise	A	0.88	20,000	17,600	20,000
Jul 15 2019	NVUS	Novus Therapeutics ...	Chimovits Erez	Director	Option Exercise	A	0.88	20,000	17,600	20,000
Jul 15 2019	NVUS	Novus Therapeutics ...	LYONS GARY A	Director	Option Exercise	A	0.88	20,000	17,600	20,000
Jul 15 2019	NVUS	Novus Therapeutics ...	Cohen Cheryl	Director	Option Exercise	A	0.88	20,000	17,600	20,000
May 22 2019	NVUS	Novus Therapeutics ...	TURKEL CATHERINE C.	President	Sell	S	1.91	1,914	3,658	88,662	90.6 K to 88.7 K (-2.11 %)
May 22 2019	NVUS	Novus Therapeutics ...	TURKEL CATHERINE C.	President	Sell	S	1.96	7,623	14,953	90,576	98.2 K to 90.6 K (-7.76 %)
May 22 2019	NVUS	Novus Therapeutics ...	Kuwahara Jon	See Remarks	Sell	S	1.91	1,058	2,022	5,974	7 K to 6 K (-15.05 %)
May 22 2019	NVUS	Novus Therapeutics ...	Kuwahara Jon	See Remarks	Sell	S	1.96	4,218	8,274	7,032	11.3 K to 7 K (-37.49 %)
May 22 2019	NVUS	Novus Therapeutics ...	FLESHER GREGORY J.	Chief Executive Off ...	Sell	S	1.91	2,937	5,614	156,918	159.9 K to 156.9 K (-1.84 %)
May 22 2019	NVUS	Novus Therapeutics ...	FLESHER GREGORY J.	Chief Executive Off ...	Sell	S	1.96	11,701	22,953	159,855	171.6 K to 159.9 K (-6.82 %)
May 06 2019	NVUS	Novus Therapeutics ...	OrbiMed Israel GP Ltd.	Director	Option Exercise	P	0.00	646,204	0	646,204
May 06 2019	NVUS	Novus Therapeutics ...	OrbiMed Israel GP Ltd.	Director	Option Exercise	P	0.00	646,204	0	646,204
May 06 2019	NVUS	Novus Therapeutics ...	OrbiMed Israel GP Ltd.	Director	Buy	P	3.10	646,204	2,003,232	3,183,314	2.5 M to 3.2 M (+25.47 %)
May 06 2019	NVUS	Novus Therapeutics ...	Chimovits Erez	Director	Option Exercise	P	0.00	646,204	0	646,204
May 06 2019	NVUS	Novus Therapeutics ...	Chimovits Erez	Director	Option Exercise	P	0.00	646,204	0	646,204
May 06 2019	NVUS	Novus Therapeutics ...	Chimovits Erez	Director	Buy	P	3.10	646,204	2,003,232	3,183,314	2.5 M to 3.2 M (+25.47 %)
May 02 2019	NVUS	Novus Therapeutics ...	LIFESCI INDEX PARTNERS LLC	10% Owner	Sell	S	2.70	200	540	1,065,867	1.1 M to 1.1 M (-0.02 %)
May 02 2019	NVUS	Novus Therapeutics ...	LIFESCI INDEX PARTNERS LLC	10% Owner	Sell	S	2.70	200	540	1,065,867	1.1 M to 1.1 M (-0.02 %)
Mar 18 2019	NVUS	Novus Therapeutics ...	TURKEL CATHERINE C.	President	Option Exercise	A	3.72	50,000	186,000	50,000
Mar 18 2019	NVUS	Novus Therapeutics ...	TURKEL CATHERINE C.	President	Grant	A	0.00	20,000	0	98,199	78.2 K to 98.2 K (+25.58 %)
Mar 18 2019	NVUS	Novus Therapeutics ...	FLESHER GREGORY J.	Chief Executive Off ...	Option Exercise	A	3.72	90,000	334,800	90,000
Mar 18 2019	NVUS	Novus Therapeutics ...	FLESHER GREGORY J.	Chief Executive Off ...	Grant	A	0.00	25,000	0	171,556	146.6 K to 171.6 K (+17.06 %)
Sep 13 2018	NVUS	Novus Therapeutics ...	TURKEL CATHERINE C.	President	Buy	P	5.02	16,632	83,476	78,199	61.6 K to 78.2 K (+27.01 %)
Sep 13 2018	NVUS	Novus Therapeutics ...	TURKEL CATHERINE C.	President	Buy	P	4.56	17,048	77,671	61,567	44.5 K to 61.6 K (+38.29 %)
Sep 07 2018	NVUS	Novus Therapeutics ...	TURKEL CATHERINE C.	President	Buy	P	3.97	805	3,193	805	0 to 805
Sep 07 2018	NVUS	Novus Therapeutics ...	TURKEL CATHERINE C.	President	Buy	P	3.97	805	3,193	805	0 to 805
Jun 14 2018	NVUS	Novus Therapeutics ...	Cohen Cheryl	Director	Option Exercise	A	6.18	9,100	56,238	9,100
Jun 14 2018	NVUS	Novus Therapeutics ...	LYONS GARY A	Director	Option Exercise	A	6.18	9,100	56,238	9,100
Jun 14 2018	NVUS	Novus Therapeutics ...	Katkin Keith	Director	Option Exercise	A	6.18	9,100	56,238	9,100
Jun 14 2018	NVUS	Novus Therapeutics ...	McBride John S.	Director	Option Exercise	A	6.18	9,100	56,238	9,100
Mar 15 2018	TKAI	Novus Therapeutics ...	Kuwahara Jon	See Remarks	Option Exercise	A	4.83	12,000	57,960	12,000
Mar 15 2018	TKAI	Novus Therapeutics ...	Kuwahara Jon	See Remarks	Grant	A	0.00	11,250	0	11,250	0 to 11.3 K
Mar 15 2018	TKAI	Novus Therapeutics ...	FLESHER GREGORY J.	Chief Executive Off ...	Option Exercise	A	4.83	56,500	272,895	56,500
Mar 15 2018	TKAI	Novus Therapeutics ...	FLESHER GREGORY J.	Chief Executive Off ...	Grant	A	0.00	30,700	0	146,556	115.9 K to 146.6 K (+26.50 %)
Mar 15 2018	TKAI	Novus Therapeutics ...	TURKEL CATHERINE C.	President	Option Exercise	A	4.83	24,000	115,920	24,000
Mar 15 2018	TKAI	Novus Therapeutics ...	TURKEL CATHERINE C.	President	Grant	A	0.00	20,000	0	44,519	24.5 K to 44.5 K (+81.57 %)
Nov 06 2017	TKAI	Novus Therapeutics ...	TURKEL CATHERINE C.	President	Option Exercise	A	4.21	50,000	210,500	50,000
Jul 10 2017	TKAI	Novus Therapeutics ...	Kuwahara Jon	See Remarks	Option Exercise	A	5.61	35,000	196,350	35,000
Jul 05 2017	TKAI	Novus Therapeutics ...	LYONS GARY A	Director	Option Exercise	A	5.85	18,000	105,300	18,000
Jul 05 2017	TKAI	Novus Therapeutics ...	McBride John S.	Director	Option Exercise	A	5.85	18,000	105,300	18,000
May 26 2017	TKAI	Novus Therapeutics ...	FLESHER GREGORY J.	Chief Executive Off ...	Option Exercise	A	5.50	250,000	1,375,000	250,000
May 26 2017	TKAI	Novus Therapeutics ...	TURKEL CATHERINE C.	Chief Development O ...	Option Exercise	A	5.50	52,500	288,750	52,500
May 11 2017	TKAI	Novus Therapeutics ...	FLESHER GREGORY J.	Chief Executive Off ...	Buy	P	9.99	58,959	589,000	115,856	56.9 K to 115.9 K (+103.62 %)
May 11 2017	TKAI	Novus Therapeutics ...	TURKEL CATHERINE C.	Chief Development O ...	Buy	P	9.99	11,111	110,999	24,519	13.4 K to 24.5 K (+82.87 %)
May 11 2017	TKAI	Novus Therapeutics ...	OCAMPO CHRISTINE	See Remarks	Buy	P	9.99	10,010	100,000	21,590	11.6 K to 21.6 K (+86.44 %)
May 11 2017	TKAI	Novus Therapeutics ...	OrbiMed Israel GP Ltd.	Director	Grant	A	0.00	2,537,110	0	2,537,110	0 to 2.5 M
Jun 16 2016	TKAI	Tokai Pharmaceutic ...	Yanchik Joseph A., III		Option Exercise	A	6.29	12,000	75,480	12,000
Jun 16 2016	TKAI	Tokai Pharmaceutic ...	Cohen Cheryl		Option Exercise	A	6.29	12,000	75,480	12,000
Jun 16 2016	TKAI	Tokai Pharmaceutic ...	Kessler David A.		Option Exercise	A	6.29	12,000	75,480	12,000
Jun 16 2016	TKAI	Tokai Pharmaceutic ...	Buckley Stephen Jr.		Option Exercise	A	6.29	12,000	75,480	12,000
Jun 16 2016	TKAI	Tokai Pharmaceutic ...	BARBERICH TIMOTHY J		Option Exercise	A	6.29	12,000	75,480	12,000
Jun 16 2016	TKAI	Tokai Pharmaceutic ...	Harrison Seth Loring		Option Exercise	A	6.29	12,000	75,480	12,000
Mar 15 2016	TKAI	Tokai Pharmaceutic ...	Buckley Stephen Jr.		Buy	P	5.74	8,000	45,920	11,000	3 K to 11 K (+266.67 %)
Jan 08 2016	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Option Exercise	M	1.37	20,000	27,400	37,878
Jan 08 2016	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Option Exercise	M	0.63	8,015	5,049	0
Jan 08 2016	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Buy	M	1.37	20,000	27,400	57,566	37.6 K to 57.6 K (+53.24 %)
Jan 08 2016	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Buy	M	0.63	8,015	5,049	37,566	29.6 K to 37.6 K (+27.12 %)
Dec 17 2015	TKAI	Tokai Pharmaceutic ...	Ferrante Karen Jean	Head Res. & Dev. & ...	Option Exercise	A	9.65	62,000	598,300	62,000
Dec 17 2015	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Option Exercise	A	9.65	189,000	1,823,850	189,000
Dec 17 2015	TKAI	Tokai Pharmaceutic ...	Kalowski Lee	Chief Financial Off ...	Option Exercise	A	9.65	62,000	598,300	62,000
Dec 17 2015	TKAI	Tokai Pharmaceutic ...	Quirk Gerald E	General Counsel, Ex ...	Option Exercise	A	9.65	62,000	598,300	62,000
Dec 17 2015	TKAI	Tokai Pharmaceutic ...	McBride John S.	Chief Operating Off ...	Option Exercise	A	9.65	62,000	598,300	62,000
Nov 12 2015	TKAI	Tokai Pharmaceutic ...	Buckley Stephen Jr.		Buy	P	11.25	3,000	33,750	3,000	0 to 3 K
Sep 22 2015	TKAI	Tokai Pharmaceutic ...	McBride John S.	Chief Operating Off ...	Option Exercise	M	4.19	13,500	56,565	186,678
Sep 22 2015	TKAI	Tokai Pharmaceutic ...	McBride John S.	Chief Operating Off ...	Sell	S	14.01	13,500	189,135	0	13.5 K to 0 (-100.00 %)
Sep 22 2015	TKAI	Tokai Pharmaceutic ...	McBride John S.	Chief Operating Off ...	Buy	M	4.19	13,500	56,565	13,500	0 to 13.5 K
Sep 08 2015	TKAI	Tokai Pharmaceutic ...	Kalowski Lee	Chief Financial Off ...	Sell	S	13.13	4,668	61,291	40,953	45.6 K to 41 K (-10.23 %)
Sep 04 2015	TKAI	Tokai Pharmaceutic ...	Kalowski Lee	Chief Financial Off ...	Sell	S	12.96	2,158	27,968	45,621	47.8 K to 45.6 K (-4.52 %)
Jul 30 2015	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Option Exercise	M	1.37	3,000	4,110	57,878
Jul 30 2015	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Option Exercise	M	0.63	7,000	4,410	8,015
Jul 30 2015	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Option Exercise	M	1.58	564	891	312,736
Jul 30 2015	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Option Exercise	M	1.58	12,000	18,960	313,300
Jul 30 2015	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Buy	M	1.37	3,000	4,110	29,551	26.6 K to 29.6 K (+11.30 %)
Jul 30 2015	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Buy	M	0.63	7,000	4,410	26,551	19.6 K to 26.6 K (+35.80 %)
Jul 30 2015	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Sell	S	13.70	564	7,727	19,551	20.1 K to 19.6 K (-2.80 %)
Jul 30 2015	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Buy	M	1.58	564	891	20,115	19.6 K to 20.1 K (+2.88 %)
Jul 30 2015	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Sell	S	13.70	12,000	164,400	19,551	31.6 K to 19.6 K (-38.03 %)
Jul 30 2015	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Buy	M	1.58	12,000	18,960	31,551	19.6 K to 31.6 K (+61.38 %)
Jul 24 2015	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Option Exercise	M	0.63	7,426	4,678	15,015
Jul 24 2015	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Option Exercise	M	2.31	2,574	5,946	0
Jul 24 2015	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Buy	M	0.63	7,426	4,678	19,551	12.1 K to 19.6 K (+61.25 %)
Jul 24 2015	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Buy	M	2.31	2,574	5,946	12,125	9.6 K to 12.1 K (+26.95 %)
Jul 17 2015	TKAI	Tokai Pharmaceutic ...	Novartis Bioventures Ltd	10% Owner	Sell	S	14.26	3,566	50,844	4,493,458	4.5 M to 4.5 M (-0.08 %)
Jul 15 2015	TKAI	Tokai Pharmaceutic ...	Novartis Bioventures Ltd	10% Owner	Sell	S	14.41	27,861	401,477	4,497,024	4.5 M to 4.5 M (-0.62 %)
Jul 15 2015	TKAI	Tokai Pharmaceutic ...	Novartis Bioventures Ltd	10% Owner	Sell	S	14.20	20,611	292,717	4,524,885	4.5 M to 4.5 M (-0.45 %)
Jun 30 2015	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Option Exercise	M	1.58	8,000	12,640	325,300
Jun 30 2015	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Option Exercise	M	1.58	8,000	12,640	333,300
Jun 30 2015	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Sell	S	13.70	8,000	109,600	9,551	17.6 K to 9.6 K (-45.58 %)
Jun 30 2015	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Buy	M	1.58	8,000	12,640	17,551	9.6 K to 17.6 K (+83.76 %)
Jun 30 2015	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Sell	S	13.83	8,000	110,640	9,551	17.6 K to 9.6 K (-45.58 %)
Jun 30 2015	TKAI	Tokai Pharmaceutic ...	Morrison Jodie Pope	President and CEO	Buy	M	1.58	8,000	12,640	17,551	9.6 K to 17.6 K (+83.76 %)
Jun 24 2015	TKAI	Tokai Pharmaceutic ...	McBride John S.	Chief Operating Off ...	Option Exercise	M	4.19	300	1,257	200,178
Jun 24 2015	TKAI	Tokai Pharmaceutic ...	McBride John S.	Chief Operating Off ...	Option Exercise	M	4.19	6,700	28,073	200,478
Jun 24 2015	TKAI	Tokai Pharmaceutic ...	McBride John S.	Chief Operating Off ...	Option Exercise	M	4.19	2,000	8,380	207,178
Jun 24 2015	TKAI	Tokai Pharmaceutic ...	McBride John S.	Chief Operating Off ...	Sell	S	14.20	300	4,260	0	300 to 0 (-100.00 %)
Jun 24 2015	TKAI	Tokai Pharmaceutic ...	McBride John S.	Chief Operating Off ...	Buy	M	4.19	300	1,257	300	0 to 300
Jun 24 2015	TKAI	Tokai Pharmaceutic ...	McBride John S.	Chief Operating Off ...	Sell	S	14.00	6,700	93,800	0	6.7 K to 0 (-100.00 %)
Jun 24 2015	TKAI	Tokai Pharmaceutic ...	McBride John S.	Chief Operating Off ...	Buy	M	4.19	6,700	28,073	6,700	0 to 6.7 K
Jun 24 2015	TKAI	Tokai Pharmaceutic ...	McBride John S.	Chief Operating Off ...	Sell	S	14.02	2,000	28,040	0	2 K to 0 (-100.00 %)
Jun 24 2015	TKAI	Tokai Pharmaceutic ...	McBride John S.	Chief Operating Off ...	Buy	M	4.19	2,000	8,380	2,000	0 to 2 K
Jun 19 2015	TKAI	Tokai Pharmaceutic ...	Buckley Stephen Jr.		Option Exercise	A	14.04	12,000	168,480	12,000
Jun 19 2015	TKAI	Tokai Pharmaceutic ...	Yanchik Joseph A., III		Option Exercise	A	14.04	12,000	168,480	12,000
Jun 19 2015	TKAI	Tokai Pharmaceutic ...	Kessler David A.		Option Exercise	A	14.04	12,000	168,480	12,000
Jun 19 2015	TKAI	Tokai Pharmaceutic ...	Harrison Seth Loring		Option Exercise	A	14.04	12,000	168,480	12,000
Jun 19 2015	TKAI	Tokai Pharmaceutic ...	BARBERICH TIMOTHY J		Option Exercise	A	14.04	12,000	168,480	12,000
Jun 18 2015	TKAI	Tokai Pharmaceutic ...	Novartis Bioventures Ltd	10% Owner	Sell	S	14.27	1,120	15,982	4,545,496	4.5 M to 4.5 M (-0.02 %)
Jun 16 2015	TKAI	Tokai Pharmaceutic ...	Novartis Bioventures Ltd	10% Owner	Sell	S	14.20	14,777	209,833	4,546,616	4.6 M to 4.5 M (-0.32 %)

Page: 1 2 next >